Patent · US Active

1, 4, 8-triazaphenanthrene derivatives for the treatment of neurodegenerative disorders

US10550115B2 · kind B2 · utility

0Cited by

0References

15Claims

0Family size

Assignees

INSTITUT DU CERVEAU ET DE LA MOELLE EPINIERE · FR
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE · FR
Sorbonne Universite · FR
ASSISTANCE PUBLIQUE—HÔPITAUX DE PARIS (APHP) · FR
Institut National de la Sante et de la Recherche Medicale (INSERM) · FR
UNIVERSITÉ PARIS-SUD · DE

Inventors

Bruno Figadere · Cluses, FR
Laurent Ferrie · Palaiseau, FR
Gael Le Douaron · Brioude, FR
Rita Raisman-Vozari · Paris, FR
Patrick MICHEL · Paris, FR
Julia Sepulveda · Paris, FR

Key dates

Filing date	Oct 10, 2016
Grant date	Feb 4, 2020
Priority date	—
Expiry date	Oct 10, 2036

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P25/28
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to compounds of formula (I), particularly for the use thereof as a medicament, especially in the treatment or prevention of neurogenerative disorders. The invention also relates to the methods for producing said compounds, and to the pharmaceutical compositions containing same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.